Showing results (1-10 of 249) with videos related to

Sort By:
Pageof 25
Seminars in Nuclear Medicine|December 14, 2025
Treatment response assessment according to updated PROMISE criteriaTugce Telli, Caner Civan, Ken Herrmann, et al.
Expert Review of Molecular Diagnostics|September 30, 2016
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancerMartin Barrio, Wolfgang P Fendler, Johannes Czernin, et al.
Radiologie (Heidelberg, Germany)|February 17, 2026
[Positron emission tomography in sarcomas]Wolfgang P Fendler, Lukas Kessler, Stephan Himmen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 21, 2026
FDG PET Hybrid ImagingCaner Civan, Wolfgang P Fendler, Bernd J Krause, et al.
Urologie (Heidelberg, Germany)|August 27, 2025
[PSMA radioligand therapy-State of the art]Christoph Berliner, Viktor Grünwald, Ulrich Krafft, et al.
Seminars in Nuclear Medicine|July 17, 2025
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An UpdateKim M Pabst, Wolfgang P Fendler, Leonie S Jochheim, et al.
Der Urologe. Ausg. A|February 9, 2022
[Prostate-specific membrane antigen positron emission tomography (PSMA PET) for urologists-when and which tracer?]Christoph Berliner, Claudia Kesch, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2017
177Lu-PSMA Radioligand Therapy for Prostate CancerWolfgang P Fendler, Kambiz Rahbar, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer RecurrenceJeremie Calais, Wolfgang P Fendler, Ken Herrmann, et al.
Pageof 25